Overview
Date and Time:
Day 1: May 18 2026, from 9:00 AM to 5:00 PM
Day 2: May 19 2026, from 9:00 AM to 12:00 PM
Location: The meeting is set to take place at the National Cancer Institute - Shady Grove (9609 Medical Center Dr., Rockville, MD 20850).
Meeting Description: The objective of the Pancreatic Cancer Detection Consortium (PCDC) is to develop and test new molecular and imaging biomarkers to improve the detection of early-stage pancreatic ductal adenocarcinoma (PDAC) and its precursor lesions and identify individuals who are at high risk of developing PDAC and are candidates for early intervention.